Literature DB >> 1415528

Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits.

J Baron1, Z Huang, K E Oerter, J D Bacher, G B Cutler.   

Abstract

Excess glucocorticoid is a potent inhibitor of epiphysial growth. Several mechanisms have been suggested to explain this growth inhibition, including both direct local effects of glucocorticoid on the epiphysial growth plate and indirect systemic effects. Previous studies do not distinguish which of these proposed mechanisms is actually responsible for the growth suppression in vivo. To resolve this controversy, we developed a method for delivering glucocorticoid directly into the rabbit epiphysial growth plate and for accurately measuring the resulting epiphysial growth rate. Five-week-old male rabbits received a local infusion of dexamethasone phosphate (80 ng/microliters, 1 microliters/h) into one proximal tibial growth plate and an infusion of vehicle into the contralateral growth plate. Growth rate was determined by inserting metal pins into the bone immediately adjacent to the growth plate and measuring the change in distance between pins on serial radiographs. This method permitted growth rates to be measured over intervals as short as 3 days, with an error of approximately 5%. Local dexamethasone administration decreased proximal tibial growth rate by 77% compared with the contralateral vehicle-treated tibia (P less than 0.0001). We conclude that excess glucocorticoid causes a rapid potent inhibition of growth by a direct local action on the growth plate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415528     DOI: 10.1152/ajpendo.1992.263.3.E489

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  20 in total

1.  In vivo NMR microscopy allows short-term serial assessment of multiple skeletal implications of corticosteroid exposure.

Authors:  Masaya Takahashi; Felix W Wehrli; Luna Hilaire; Babette S Zemel; Scott N Hwang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  The impact of corticosteroids on growth and bone health.

Authors:  T Mushtaq; S F Ahmed
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

3.  The role of glucocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic lineage: positive and negative effects.

Authors:  A Scutt; P Bertram; M Bräutigam
Journal:  Calcif Tissue Int       Date:  1996-09       Impact factor: 4.333

4.  Bone age and factors affecting skeletal maturation at diagnosis of paediatric Cushing's disease.

Authors:  Shrikrishna V Acharya; Raju A Gopal; Anurag Lila; Padma S Menon; Tushar R Bandgar; Nalini S Shah
Journal:  Pituitary       Date:  2010-12       Impact factor: 4.107

Review 5.  Short and tall stature: a new paradigm emerges.

Authors:  Jeffrey Baron; Lars Sävendahl; Francesco De Luca; Andrew Dauber; Moshe Phillip; Jan M Wit; Ola Nilsson
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

Review 6.  Effects of glucocorticoids on the growth plate.

Authors:  Julian C Lui; Jeffrey Baron
Journal:  Endocr Dev       Date:  2010-12-16

7.  Thyroid hormone, but not parathyroid hormone, partially restores glucocorticoid-induced growth retardation.

Authors:  Sylvia C van Buul-Offers; Jeske J Smink; Ria Gresnigt; Nicole Hamers; Joost Koedam; Marcel Karperien
Journal:  Pediatr Nephrol       Date:  2005-02-02       Impact factor: 3.714

8.  Age and pattern of the onset of differential growth among growth plates in rats.

Authors:  Norman J Wilsman; Elizabeth S Bernardini; Ellen Leiferman; Ken Noonan; Cornelia E Farnum
Journal:  J Orthop Res       Date:  2008-11       Impact factor: 3.494

9.  The Biology of Stature.

Authors:  Youn Hee Jee; Jeffrey Baron
Journal:  J Pediatr       Date:  2016-03-26       Impact factor: 4.406

Review 10.  Nitric oxide, C-type natriuretic peptide and cGMP as regulators of endochondral ossification.

Authors:  Cristina C Teixeira; Hanga Agoston; Frank Beier
Journal:  Dev Biol       Date:  2008-05-03       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.